124 related articles for article (PubMed ID: 15100248)
1. C-kit gene product (CD117) immunoreactivity in canine and feline paraffin sections.
Morini M; Bettini G; Preziosi R; Mandrioli L
J Histochem Cytochem; 2004 May; 52(5):705-8. PubMed ID: 15100248
[TBL] [Abstract][Full Text] [Related]
2. Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders.
Arber DA; Tamayo R; Weiss LM
Hum Pathol; 1998 May; 29(5):498-504. PubMed ID: 9596274
[TBL] [Abstract][Full Text] [Related]
3. [The diagnostic and predictive role of kit (CD117)].
Dirnhofer S; Zimpfer A; Went P
Ther Umsch; 2006 Apr; 63(4):273-8. PubMed ID: 16689459
[TBL] [Abstract][Full Text] [Related]
4. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.
Sarlomo-Rikala M; Kovatich AJ; Barusevicius A; Miettinen M
Mod Pathol; 1998 Aug; 11(8):728-34. PubMed ID: 9720500
[TBL] [Abstract][Full Text] [Related]
5. CD117 expression in glial tumors.
Cetin N; Dienel G; Gokden M
J Neurooncol; 2005 Nov; 75(2):195-202. PubMed ID: 16132504
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of Kit receptor tyrosine kinase dysregulations in feline cutaneous mast cell tumors.
Sabattini S; Guadagni Frizzon M; Gentilini F; Turba ME; Capitani O; Bettini G
Vet Pathol; 2013 Sep; 50(5):797-805. PubMed ID: 23377219
[TBL] [Abstract][Full Text] [Related]
8. Strong PDGFRA positivity is seen in GISTs but not in other intra-abdominal mesenchymal tumors: Immunohistochemical and mutational analyses.
Peterson MR; Piao Z; Weidner N; Yi ES
Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):390-6. PubMed ID: 17122634
[TBL] [Abstract][Full Text] [Related]
9. [Expression and gene mutation of phospho-platelet derived growth factor receptor alpha and C-kit in gastrointestinal and extra-gastrointestinal stromal tumors].
Tang M; Li DQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan; 11(1):80-3. PubMed ID: 18197502
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers?
Ríos-Moreno MJ; Jaramillo S; Pereira Gallardo S; Vallejo A; Mora M; García-Escudero A; Amérigo J; González-Cámpora R
Pathol Res Pract; 2012 Feb; 208(2):74-81. PubMed ID: 22197035
[TBL] [Abstract][Full Text] [Related]
11. Kit (CD117) immunoreactivity is rare in renal cell and upper urinary tract transitional cell carcinomas.
Zigeuner R; Ratschek M; Langner C
BJU Int; 2005 Feb; 95(3):315-8. PubMed ID: 15679785
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors.
Sabattini S; Bettini G
Vet Pathol; 2010 Jul; 47(4):643-53. PubMed ID: 20418469
[TBL] [Abstract][Full Text] [Related]
13. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
14. Mast cells or not? - CD117 positive cells in esophageal leiomyoma.
Ye JX; Liu Y; Qin Y; Ma XL; Zhong HH; Zhang Y; Shi XY
Histol Histopathol; 2015 May; 30(5):581-8. PubMed ID: 25487836
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of tyrosine kinases and use of imatinib in small animal practice.
Bonkobara M
Vet J; 2015 Aug; 205(2):180-8. PubMed ID: 25592261
[TBL] [Abstract][Full Text] [Related]
16. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation.
Miettinen M; Lasota J
Appl Immunohistochem Mol Morphol; 2005 Sep; 13(3):205-20. PubMed ID: 16082245
[TBL] [Abstract][Full Text] [Related]
17. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit.
Miettinen M; Sarlomo-Rikala M; Lasota J
Mod Pathol; 2000 May; 13(5):536-41. PubMed ID: 10824925
[TBL] [Abstract][Full Text] [Related]
18. Expression of the c-kit gene product in normal and neoplastic mast cells but not in neoplastic basophil/mast cell precursors from chronic myelogenous leukaemia.
Fukuda T; Kamishima T; Tsuura Y; Suzuki T; Kakihara T; Naito M; Kishi K; Matsumoto K; Shibata A; Seito T
J Pathol; 1995 Oct; 177(2):139-46. PubMed ID: 7490680
[TBL] [Abstract][Full Text] [Related]
19. Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms.
Ma Y; Longley BJ; Wang X; Blount JL; Langley K; Caughey GH
J Invest Dermatol; 1999 Feb; 112(2):165-70. PubMed ID: 9989791
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal stromal tumors express ras oncogene: a potential role for diagnosis and treatment.
Blair SL; Al-Refaie WB; Wang-Rodriguez J; Behling C; Ali MW; Moossa AR
Arch Surg; 2005 Jun; 140(6):543-7; discussion 547-8. PubMed ID: 15967901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
